ストックスクリーナーアプリを入手
287.36
0.44%
-1.27
アフターアワーズ：
285.69
-1.67
-0.58%
前日終値:
$288.63
開ける：
$289.26
24時間の取引高:
570.08K
Relative Volume:
0.87
時価総額：
$20.21B
収益：
$2.36B
当期純損益:
$236.10M
株価収益率:
87.45
EPS:
3.286
ネットキャッシュフロー:
$382.50M
1週間 パフォーマンス:
-1.44%
1か月 パフォーマンス:
-12.17%
6か月 パフォーマンス:
-8.22%
1年 パフォーマンス:
+8.39%
1日の値動き範囲:
$285.58
$290.60
1週間の範囲:
$285.02
$292.75
52週間の値動き範囲:
$230.05
$354.88
Insulet Corporation Stock (PODD) Company Profile
PODD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PODD
Insulet Corporation
|
287.36 | 20.30B | 2.36B | 236.10M | 382.50M | 3.286 |
|
ABT
Abbott Laboratories
|
124.57 | 217.08B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
95.76 | 142.40B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
352.50 | 135.46B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
96.13 | 123.74B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
86.94 | 50.40B | 5.88B | 1.34B | 799.60M | 2.3489 |
Insulet Corporation Stock (PODD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-16 | 開始されました | Evercore ISI | Outperform |
| 2025-11-19 | アップグレード | UBS | Neutral → Buy |
| 2025-10-21 | 再開されました | Stifel | Buy |
| 2025-09-08 | 再開されました | Oppenheimer | Outperform |
| 2025-06-16 | 開始されました | Truist | Buy |
| 2025-05-30 | 開始されました | Goldman | Buy |
| 2025-05-13 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-04-29 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2025-03-06 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-11-06 | 開始されました | Bernstein | Outperform |
| 2024-05-30 | 開始されました | Redburn Atlantic | Buy |
| 2024-05-07 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2023-12-21 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2023-12-04 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-02 | アップグレード | Jefferies | Hold → Buy |
| 2023-08-21 | アップグレード | Citigroup | Neutral → Buy |
| 2023-08-21 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2023-05-30 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-01-26 | 開始されました | Wolfe Research | Peer Perform |
| 2022-11-04 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-10-18 | 開始されました | Barclays | Equal Weight |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-07-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-02-03 | アップグレード | BTIG Research | Neutral → Buy |
| 2022-02-02 | アップグレード | UBS | Neutral → Buy |
| 2022-01-31 | アップグレード | Oppenheimer | Perform → Outperform |
| 2021-07-21 | 再開されました | Cowen | Outperform |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-01 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2021-03-19 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2021-01-29 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-07-28 | 開始されました | Wells Fargo | Overweight |
| 2020-04-24 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-03 | 開始されました | BofA/Merrill | Neutral |
| 2020-03-31 | ダウングレード | Berenberg | Buy → Hold |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2019-12-10 | 開始されました | CFRA | Sell |
| 2019-10-23 | 開始されました | Stifel | Hold |
| 2019-10-18 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2019-10-14 | ダウングレード | BTIG Research | Buy → Neutral |
| 2019-10-04 | ダウングレード | UBS | Buy → Neutral |
| 2019-10-03 | ダウングレード | Guggenheim | Buy → Neutral |
| 2019-08-06 | アップグレード | JP Morgan | Neutral → Overweight |
| 2019-06-10 | ダウングレード | Northland Capital | Outperform → Market Perform |
| 2019-05-06 | アップグレード | BTIG Research | Neutral → Buy |
| 2018-04-20 | 開始されました | Berenberg | Buy |
| 2018-02-22 | 繰り返されました | Barclays | Overweight |
| 2018-01-08 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2017-11-03 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2017-09-15 | 開始されました | Barclays | Overweight |
すべてを表示
Insulet Corporation (PODD) 最新ニュース
From Edwards to Insulet: Three key medical device cases of 2025 - Life Sciences Intellectual Property Review
Swedbank AB Buys 5,000 Shares of Insulet Corporation $PODD - MarketBeat
Osaic Holdings Inc. Purchases 5,309 Shares of Insulet Corporation $PODD - MarketBeat
Beacon Investment Advisory Services Inc. Has $25.11 Million Stake in Insulet Corporation $PODD - MarketBeat
3 Reasons Growth Investors Will Love Insulet (PODD) - sharewise.com
Insulet Corporation $PODD Holdings Decreased by Squarepoint Ops LLC - MarketBeat
Insulet Corporation $PODD Shares Acquired by Munro Partners - MarketBeat
Insulet Corp. Stock Underperforms Tuesday When Compared To Competitors - 富途牛牛
Insulin Delivery Devices Market Outlook: Market to Reach US$ - openPR.com
Patton Fund Management Inc. Buys 13,972 Shares of Insulet Corporation $PODD - MarketBeat
Why Insulet (PODD) is a Top Growth Stock for the Long-Term - sharewise.com
Insulet Corporation's (NASDAQ:PODD) Business Is Yet to Catch Up With Its Share Price - 富途牛牛
Truist Cuts Insulet (PODD) PT but Maintains Buy as Top MedTech Pick for 2026 - Insider Monkey
Is Insulet Fairly Priced After Its Strong Run and High Earnings Multiple in 2025? - simplywall.st
Voya Investment Management LLC Has $19.59 Million Stock Holdings in Insulet Corporation $PODD - MarketBeat
(PODD) Risk Channels and Responsive Allocation - Stock Traders Daily
Tubeless Insulin Pumps Market Size, Share, Trends | Top - openPR.com
Congress Asset Management Co. Acquires 9,976 Shares of Insulet Corporation $PODD - MarketBeat
Why Insulet Corporation (GOV) stock is a strong analyst pick2025 Technical Patterns & AI Powered Market Entry Strategies - Улправда
Perpetual Ltd Sells 5,898 Shares of Insulet Corporation $PODD - MarketBeat
Should Insulet’s (PODD) Expanded Pod Recycling Effort Reframe Its Long‑Term Sustainability Edge? - Yahoo Finance UK
Guidance Update: Can Insulet Corporation (GOV) stock sustain revenue momentum2025 Growth vs Value & Weekly Breakout Watchlists - moha.gov.vn
Insulet appoints PwC as new auditor for 2026, replaces Grant Thornton By Investing.com - Investing.com Nigeria
Insulet appoints PwC as new auditor for 2026, replaces Grant Thornton - Investing.com Nigeria
Insulet Corp. stock underperforms Friday when compared to competitors - MarketWatch
Returns Recap: Will Insulet Corporation stock outperform value stocksIPO Watch & Risk Controlled Daily Trade Plans - Улправда
Why analysts upgrade Insulet Corporation stockTrade Analysis Summary & Free Accurate Trade Setup Notifications - DonanımHaber
FOMO Trade: Why Insulet Corporation stock attracts high net worth investorsJuly 2025 Market Mood & Weekly Chart Analysis and Trade Guides - Улправда
Why institutional investors increase stakes in Insulet Corporation (GOV) stockJuly 2025 Intraday Action & Expert Approved Trade Ideas - DonanımHaber
Texas Permanent School Fund Corp Purchases 3,633 Shares of Insulet Corporation $PODD - MarketBeat
Why Insulet Corporation stock attracts global investorsExit Point & Short-Term Swing Trade Alerts - Улправда
Assenagon Asset Management S.A. Raises Stock Position in Insulet Corporation $PODD - MarketBeat
Is Insulet Corporation (GOV) stock positioned for digital growth era2025 Risk Factors & Low Drawdown Investment Ideas - DonanımHaber
What margin trends mean for Insulet Corporation stockJuly 2025 Technicals & Growth-Oriented Investment Plans - DonanımHaber
Insulet Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Insulet stock price target lowered to $203 by BofA Securities - Investing.com South Africa
Insulet’s New Omnipod M Study Targets the Untapped Type 2 Diabetes Pump Market - TipRanks
Insulet stock price target maintained at $400 by UBS on growth outlook - Investing.com Nigeria
Insulet (PODD) Analyst Rating Update: Truist Securities Lowers P - GuruFocus
Truist Financial Issues Pessimistic Forecast for Insulet (NASDAQ:PODD) Stock Price - MarketBeat
Truist Securities Lowers Price Target on Insulet to $390 From $412, Maintains Buy Rating - marketscreener.com
UBS Reiterates Buy Rating on Insulet Corporation (PODD) - StreetInsider
Evercore ISI Begins Coverage on Insulet (NASDAQ:PODD) - MarketBeat
Why Insulet Corporation stock attracts high net worth investorsIndex Update & Risk Controlled Swing Alerts - Улправда
Insulet Corporation (PODD) PT Lowered to $203 at BofA Securities - StreetInsider
Central Pacific Bank Trust Division Reduces Stock Holdings in Insulet Corporation $PODD - MarketBeat
Is Insulet stock underperforming the Nasdaq? - MSN
Insulet Corporation (PODD) Announces Amendments to Annual Incentive Plan - GuruFocus
A Look Into Insulet Inc's Price Over Earnings - Sahm
Insulet Corporation (PODD) revises Annual Incentive Plan terms for 2026 - Stock Titan
Insulet (PODD): Canaccord Genuity Raises Price Target to $450 | - GuruFocus
Insulet Corporation (PODD) 財務データ
収益
当期純利益
現金流量
EPS
0.29%
0.42%
大文字化:
|
ボリューム (24 時間):